Drawing for LIFEWARE LABS

USPTO serial 88609207

LIFEWARE LABS

Reviewed by CopyMark Law Group

Reg. 6267671Status 700Renewal
Filing date
Status date
Registration date
Feb 9, 2021
Examiner
REEVES, APRIL ELIZABETH
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with LIFEWARE LABS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $325

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael G. Monyok

Michael G. Monyok Meyer, Unkovic & Scott LLP535 Smithfield StreetSuite 1300Pittsburgh, PA 15222

Goods and services

ClassDescriptionStatusFirst use
009Wearable activity trackers; Downloadable computer application software for mobile phones, namely, software for providing activity, exercise, and fitness information received from wearable activity trackers; Flexible, body-wearable electronic devices for non-medical use for measuring the wearer's body movements while playing sports or practicing for playing sportsACTIVEAug 24, 2020

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 9, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Nov 3, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 3, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 3, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 9, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 8, 2021SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jan 7, 2021CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Dec 18, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 17, 2020SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Dec 17, 2020EX1GSOU EXTENSION 1 GRANTED—
Nov 23, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 12, 2020IUAFUSE AMENDMENT FILED—
Nov 12, 2020EXT1SOU EXTENSION 1 FILED—
Nov 12, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 12, 2020EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
May 12, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 17, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 17, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 26, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 13, 2020ALIEASSIGNED TO LIE—
Feb 9, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 8, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 7, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 7, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 17, 2019GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Dec 17, 2019GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Dec 17, 2019CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Dec 10, 2019DOCKASSIGNED TO EXAMINER—
Sep 18, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 12, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance